YaleABNLab

Official Twitter for Dr. Anahita Bassir Nia's Adversity, Brain, Novel Therapeutics (ABN) Laboratory.

[Anahita Bassir Nia @anahitabassir]

MEAI is a non-hallucinergic psychedelic with chemical structure similar to MDMA.
In this review from our lab, we discussed the potential Therapeutic use if MEAI in the treatment of alcohol use disorder (AUD).
#psychedelics
#MDMA
#MEAI
@YaleABNLab
@YalePsych

[Anahita Bassir Nia @anahitabassir]

We will discuss findings and lessons learned from our ongoing first-in-human clinical trial of MEAI in healthy participants and individuals with alcohol use disorder.

@YaleABNLab
@YalePsych

[YaleABNLab @YaleABNLab]

Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,650. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324!

[YaleABNLab @YaleABNLab]

Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,675. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324

[Anahita Bassir Nia @anahitabassir]

Excited to receive #ACNP senior researcher travel award!
Looking forward to a wonderful meeting #acnp2026 in #Bahamas (Jan 2026)!
@YalePsych
@YaleABNLab
@ACNPorg

[Anahita Bassir Nia @anahitabassir]

Will talk about #endocannabinoid system at #acnp2026.

@ACNPorg
@YalePsych
@YaleABNLab

[YaleABNLab @YaleABNLab]

Our team is currently seeking healthy volunteers age 18-60 for a psychedelic clinical trial located in New Haven, CT. Participants are eligible for compensation up to $625. If interested, please call us back at 203-974-7324!

[YaleABNLab @YaleABNLab]

Read our latest #research on the contribution of #CBD in treatment for #opioid #addiction, published with @WileyGlobal in Addiction Biology on behalf of @SSA_Addiction. Read here: https://t.co/zktG5y1aeF.

[YaleABNLab @YaleABNLab]

Yale ABNLab will be presenting at @SOBP 2025 in Toronto this week! Please see below for more details! #Neuroscience #NeuroPsych #PsychResearch #2025SOBP

[YaleABNLab @YaleABNLab]

Read our latest #research on the contribution of #psychotherapy to #psychedelic treatment for #opioid #addiction, published with @SpringerNature in Current Addiction Reports. Read here: https://t.co/wkpKlYA5JW

[YaleABNLab @YaleABNLab]

#neuroscience #psychiatry #medicalresearch #neuropsychiatry #researchstudy #clinicalresearch #researchcenter #psychology #mentalhealth #psychedelicresearch

[YaleABNLab @YaleABNLab]

https://t.co/wFAVsqEWJM

[Anahita Bassir Nia @anahitabassir]

A pre #acnp2024 #hike in #Sedona. I hiked #cathedralrock, #littlehorse, and #chapeltrail. I had underestimated #arizona sun! But the trails were wonderful!
@ACNPorg
@YaleABNLab

[YaleABNLab @YaleABNLab]

https://t.co/TQCYYSAild

[Anahita Bassir Nia @anahitabassir]

Hey @acnp. I am Anahita, an assistant professor @YalePsych. I study the #endocannabinoid system and #psychedelics in #addiction and #ptsd.
@YaleABNLab.
Looking forward to the next three days! #acnp2024

[YaleABNLab @YaleABNLab]

https://t.co/v3pTT1Q1fl

[Anahita Bassir Nia @anahitabassir]

Another poster from @YaleABNLab with @harpaz_l.
@AMohammadaghaei will present #cannabinoid receptor type 1 availability in #ptsd with #childhood_trauma today at 5pm.
#acnp2024
@ACNPorg
@YalePsych

[YaleABNLab @YaleABNLab]

https://t.co/qLL4Q1xubP

[Anahita Bassir Nia @anahitabassir]

I will present the results of my NIDA funded study on CB1R availability in opioid use disorder @ACNPorg.
#ACNP2024
@YalePsych
@YaleABNLab